Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Whitepapers
Advertising
Site Map
2023
January
26
Week in Review: Abbott sees headwinds easing; Qiagen 25-minute whole genome analysis; liquid biopsy market growth; more
AI tool makes speedy gene-editing possible, offers alternative to CRISPR
Elaborate closes $10M in financing
Unilabs, Ambry Genetics to provide genetic testing for biopharma firms in Europe, Latin America, Middle East
Consortium nabs $10M European grant to develop drug response tests for CKD
Roche launches COVID-19 PCR test to detect fast-spreading XBB.1.5 Omicron subvariant
Page 1 of 1